NCT07819513

Brief Summary

To learn if it is possible to use Apple Vision Pro (AVP) technology during image-guided procedures.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
34mo left

Started Sep 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Sep 2026Jul 2029

First Submitted

Initial submission to the registry

September 9, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

September 11, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 15, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2029

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

10 months

First QC Date

September 9, 2026

Last Update Submit

September 30, 2026

Conditions

Apple Vision ProImage Guided ProcedureSpatial Computing

Outcome Measures

Primary Outcomes (1)

  • Operator Survey Questionnaires

    Through study completion; an average of 1 year

Interventions

CT guided biopsyOTHER

While wearing the AVP headset, the operator will perform image-guided procedures.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

UT MD Anderson Cancer Center

You may qualify if:

  • Participants:
  • 18-years-old and older, any sex, race, or ethnicity, undergoing CT-guided biopsy of the abdomen or pelvis.
  • Primary operators:
  • Attending physicians in Interventional Radiology who have completed mandatory training and familiarization.

You may not qualify if:

  • Participants unable to provide informed consent or contraindications to planned procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT MD Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

Study Officials

  • Aaron K Jones, MD

    UT MD Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aaron K Jones, MD

CONTACT

713-563-0552Kyle.Jones@mdanderson.org

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2026

First Posted

September 15, 2026

Study Start

September 11, 2026

Primary Completion (Estimated)

July 15, 2027

Study Completion (Estimated)

July 15, 2029

Last Updated

October 1, 2026

Record last verified: 2026-09

Locations

US(1)